CTG Launches Application Testing Solutions in North America

A suite of Professional Services – Including Automation Intelligence-Powered “Testing-as-a-Service” – All Designed to Increase Testing Coverage and Reduce Risk

Initial Focus on the Healthcare Industry

BUFFALO, N.Y., March 05, 2020 (GLOBE NEWSWIRE) -- CTG (NASDAQ: CTG), a leading provider of information technology solutions and services in North America and Western Europe, announced today the launch of Testing Solutions in North America. Initially focused on the healthcare industry, this comprehensive suite of testing solutions provides expertise in testing healthcare applications and user customizations to avoid errors and defects that can put patient safety at risk and ultimately adversely impact a client’s financial performance.

“Our offerings in Testing Solutions demonstrate CTG’s ongoing commitment to developing industry-leading solutions that help our clients leverage technology to meet the unique challenges facing their organizations and industries,” said Filip Gydé, CTG President and Chief Executive Officer. “For example, our Testing-as-a-Service offering leverages CTG’s partnerships with industry-leading automation tool providers to revolutionize and support traditional manual, in-house testing by providing end-to-end testing support that helps healthcare organizations realize significantly improved testing results with less effort by applying the power of Automation Intelligence. TaaS enables healthcare organizations to avoid the costly issues that can occur when they assume sole responsibility for the implementation and optimization of their automated tools.”

System customizations present testing challenges

CTG Testing Solutions fills a specific healthcare industry need for application testing. In many cases, applications such as electronic health records (EHR) are highly customized to the unique needs and workflows of the organization. This reality, coupled with increasing upgrades and updates and already stretched internal HIT teams, can lead to unintended inefficiencies, workflow challenges, failure to effectively support patient care, and billing issues when these systems are not “real world” tested after each release cycle.